139 related articles for article (PubMed ID: 29969108)
1. Quantification of Total and Intracellular Sodium Concentration in Primary Prostate Cancer and Adjacent Normal Prostate Tissue With Magnetic Resonance Imaging.
Barrett T; Riemer F; McLean MA; Kaggie J; Robb F; Tropp JS; Warren A; Bratt O; Shah N; Gnanapragasam VJ; Gilbert FJ; Graves MJ; Gallagher FA
Invest Radiol; 2018 Aug; 53(8):450-456. PubMed ID: 29969108
[TBL] [Abstract][Full Text] [Related]
2. Molecular imaging of the prostate: Comparing total sodium concentration quantification in prostate cancer and normal tissue using dedicated
Barrett T; Riemer F; McLean MA; Kaggie JD; Robb F; Warren AY; Graves MJ; Gallagher FA
J Magn Reson Imaging; 2020 Jan; 51(1):90-97. PubMed ID: 31081564
[TBL] [Abstract][Full Text] [Related]
3. Everyman's prostate phantom: kiwi-fruit substitute for human prostates at magnetic resonance imaging, diffusion-weighted imaging and magnetic resonance spectroscopy.
Mueller-Lisse UG; Murer S; Mueller-Lisse UL; Kuhn M; Scheidler J; Scherr M
Eur Radiol; 2017 Aug; 27(8):3362-3371. PubMed ID: 28058480
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic evaluation of magnetization transfer and diffusion kurtosis imaging for prostate cancer detection in a re-biopsy population.
Barrett T; McLean M; Priest AN; Lawrence EM; Patterson AJ; Koo BC; Patterson I; Warren AY; Doble A; Gnanapragasam VJ; Kastner C; Gallagher FA
Eur Radiol; 2018 Aug; 28(8):3141-3150. PubMed ID: 29222677
[TBL] [Abstract][Full Text] [Related]
5. Apparent diffusion coefficient and sodium concentration measurements in human prostate tissue via hydrogen-1 and sodium-23 magnetic resonance imaging in a clinical setting at 3T.
Hausmann D; Konstandin S; Wetterling F; Haneder S; Nagel AM; Dinter DJ; Schönberg SO; Zöllner FG; Schad LR
Invest Radiol; 2012 Dec; 47(12):677-82. PubMed ID: 22996314
[TBL] [Abstract][Full Text] [Related]
6. Apparent Diffusion Coefficient Values of the Benign Central Zone of the Prostate: Comparison With Low- and High-Grade Prostate Cancer.
Gupta RT; Kauffman CR; Garcia-Reyes K; Palmeri ML; Madden JF; Polascik TJ; Rosenkrantz AB
AJR Am J Roentgenol; 2015 Aug; 205(2):331-6. PubMed ID: 26204283
[TBL] [Abstract][Full Text] [Related]
7. Relationship between T2 relaxation and apparent diffusion coefficient in malignant and non-malignant prostate regions and the effect of peripheral zone fractional volume.
Simpkin CJ; Morgan VA; Giles SL; Riches SF; Parker C; deSouza NM
Br J Radiol; 2013 Apr; 86(1024):20120469. PubMed ID: 23426849
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Sodium MR Imaging at 7 T: Initial Results and Comparison with Diffusion-weighted Imaging in Patients with Breast Tumors.
Zaric O; Pinker K; Zbyn S; Strasser B; Robinson S; Minarikova L; Gruber S; Farr A; Singer C; Helbich TH; Trattnig S; Bogner W
Radiology; 2016 Jul; 280(1):39-48. PubMed ID: 27007803
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted MRI of the prostate at 3.0 T: comparison of endorectal coil (ERC) MRI and phased-array coil (PAC) MRI-The impact of SNR on ADC measurement.
Mazaheri Y; Vargas HA; Nyman G; Shukla-Dave A; Akin O; Hricak H
Eur J Radiol; 2013 Oct; 82(10):e515-20. PubMed ID: 23810189
[TBL] [Abstract][Full Text] [Related]
10. Evolution of multi-parametric MRI quantitative parameters following transrectal ultrasound-guided biopsy of the prostate.
Latifoltojar A; Dikaios N; Ridout A; Moore C; Illing R; Kirkham A; Taylor S; Halligan S; Atkinson D; Allen C; Emberton M; Punwani S
Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):343-51. PubMed ID: 26195470
[TBL] [Abstract][Full Text] [Related]
11. In Vivo Quantification of Water Diffusion, Stiffness, and Tissue Fluidity in Benign Prostatic Hyperplasia and Prostate Cancer.
Asbach P; Ro SR; Aldoj N; Snellings J; Reiter R; Lenk J; Köhlitz T; Haas M; Guo J; Hamm B; Braun J; Sack I
Invest Radiol; 2020 Aug; 55(8):524-530. PubMed ID: 32496317
[TBL] [Abstract][Full Text] [Related]
12. Triexponential function analysis of diffusion-weighted MRI for diagnosing prostate cancer.
Ueda Y; Takahashi S; Ohno N; Kyotani K; Kawamitu H; Miyati T; Aoyama N; Ueno Y; Kitajima K; Kawakami F; Okuaki T; Tsukamoto R; Yanagita E; Sugimura K
J Magn Reson Imaging; 2016 Jan; 43(1):138-48. PubMed ID: 26119033
[TBL] [Abstract][Full Text] [Related]
13. A Single-Arm, Multicenter Validation Study of Prostate Cancer Localization and Aggressiveness With a Quantitative Multiparametric Magnetic Resonance Imaging Approach.
Maas MC; Litjens GJS; Wright AJ; Attenberger UI; Haider MA; Helbich TH; Kiefer B; Macura KJ; Margolis DJA; Padhani AR; Selnæs KM; Villeirs GM; Fütterer JJ; Scheenen TWJ
Invest Radiol; 2019 Jul; 54(7):437-447. PubMed ID: 30946180
[TBL] [Abstract][Full Text] [Related]
14. Cellular density of low-grade transition zone prostate cancer: A limiting factor to correlate restricted diffusion with tumor aggressiveness.
Barral M; Jemal-Turki A; Beuvon F; Soyer P; Camparo P; Cornud F
Eur J Radiol; 2020 Oct; 131():109230. PubMed ID: 32866908
[TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted imaging of the prostate at 3 T for differentiation of malignant and benign tissue in transition and peripheral zones: preliminary results.
Kim CK; Park BK; Han JJ; Kang TW; Lee HM
J Comput Assist Tomogr; 2007; 31(3):449-54. PubMed ID: 17538295
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
17. Probing structure of normal and malignant prostate tissue before and after radiation therapy with luminal water fraction and diffusion-weighted MRI.
Carlin D; Orton MR; Collins D; deSouza NM
J Magn Reson Imaging; 2019 Aug; 50(2):619-627. PubMed ID: 30589150
[TBL] [Abstract][Full Text] [Related]
18. T1 Mapping of the Prostate Using Single-Shot T1FLASH: A Clinical Feasibility Study to Optimize Prostate Cancer Assessment.
Al-Bourini O; Seif Amir Hosseini A; Giganti F; Balz J; Heitz LG; Voit D; Lotz J; Trojan L; Frahm J; Uhlig A; Uhlig J
Invest Radiol; 2023 Jun; 58(6):380-387. PubMed ID: 36729865
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric Magnetic Resonance Imaging for Discriminating Low-Grade From High-Grade Prostate Cancer.
Vos EK; Kobus T; Litjens GJ; Hambrock T; Hulsbergen-van de Kaa CA; Barentsz JO; Maas MC; Scheenen TW
Invest Radiol; 2015 Aug; 50(8):490-7. PubMed ID: 25867656
[TBL] [Abstract][Full Text] [Related]
20. Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy.
Wang L; Mazaheri Y; Zhang J; Ishill NM; Kuroiwa K; Hricak H
Radiology; 2008 Jan; 246(1):168-76. PubMed ID: 18024440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
